BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE and WRONG TECHNIQUE IN DEVICE USAGE PROCESS

1,087 reports of this reaction

4.7% of all BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE reports

#4 most reported adverse reaction

Overview

WRONG TECHNIQUE IN DEVICE USAGE PROCESS is the #4 most commonly reported adverse reaction for BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, manufactured by AstraZeneca Pharmaceuticals LP. There are 1,087 FDA adverse event reports linking BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE to WRONG TECHNIQUE IN DEVICE USAGE PROCESS. This represents approximately 4.7% of all 23,211 adverse event reports for this drug.

Patients taking BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE who experience wrong technique in device usage process should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

WRONG TECHNIQUE IN DEVICE USAGE PROCESS1,087 of 23,211 reports

WRONG TECHNIQUE IN DEVICE USAGE PROCESS is moderately reported among BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE users, representing a notable but not dominant share of adverse events.

Other Side Effects of BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE

In addition to wrong technique in device usage process, the following adverse reactions have been reported for BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE:

Other Drugs Associated with WRONG TECHNIQUE IN DEVICE USAGE PROCESS

The following drugs have also been linked to wrong technique in device usage process in FDA adverse event reports:

BELIMUMABFLUTICASONE FUROATEFLUTICASONE FUROATE AND VILANTEROL TRIFENATATEFLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATEFLUTICASONE PROPIONATE AND SALMETEROLSOMATROPINUMECLIDINIUMUMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE

Frequently Asked Questions

Does BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE cause WRONG TECHNIQUE IN DEVICE USAGE PROCESS?

WRONG TECHNIQUE IN DEVICE USAGE PROCESS has been reported as an adverse event in 1,087 FDA reports for BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is WRONG TECHNIQUE IN DEVICE USAGE PROCESS with BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE?

WRONG TECHNIQUE IN DEVICE USAGE PROCESS accounts for approximately 4.7% of all adverse event reports for BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, making it a notable side effect.

What should I do if I experience WRONG TECHNIQUE IN DEVICE USAGE PROCESS while taking BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE?

If you experience wrong technique in device usage process while taking BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages

BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE Full ProfileAll Drugs Causing WRONG TECHNIQUE IN DEVICE USAGE PROCESSAstraZeneca Pharmaceuticals LP Drugs
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.